Phase II Study of Gemcitabine and Docetaxel Combination in Patients with Previously Treated Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Purpose. To explore the safety and efficacy of gemcitabine and docetaxel (GEMDOC) in previously treated patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN). Patients and Methods. Patients with advanced SCCHN previously pretreated with one or two lines of pallia...

Descripción completa

Detalles Bibliográficos
Autores principales: Kafri, Zyad, Heilbrun, Lance K., Sukari, Ammar, Yoo, George, Jacobs, John, Lin, Ho-Sheng, Mulrenan, Heather, Smith, Daryn, Kucuk, Omer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scholarly Research Network 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3359684/
https://www.ncbi.nlm.nih.gov/pubmed/22655205
http://dx.doi.org/10.5402/2012/159568

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3359684/
https://www.ncbi.nlm.nih.gov/pubmed/22655205
http://dx.doi.org/10.5402/2012/159568

Ejemplares similares